General
Preferred name
TERBUTALINE
Synonyms
TERBUTALINE HEMISULFATE ()
Terbutaline,(+/-) ()
Terbasmin ()
Monovent SA ()
Monovent ()
Bricanyl Sa ()
Terbutaline sulphate ()
Terbutaline sulfuric acid ()
Terbutaline Sulfate23031-32-5 ()
Terbutaline (sulfate) ()
TERBUTALINE SULFATE ()
KWD-2019 ()
KWD 2019 ()
Bricanyl ()
Brethine ()
Brethaire ()
NSC-757336 ()
Terbutalina ()
Asthmasian ()
Terbutalin ()
Terbutaline (hemisulfate) ()
P&D ID
PD009674
CAS
23031-32-5
23031-25-6
46719-29-3
1164563-86-3
Tags
available
drug
biased GPCR ligand
Approved by
FDA
First approval
1974
Drug indication
Chronic obstructive pulmonary disease
Neuropathic pain
Asthma
Drug Status
approved
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
29
DESCRIPTION
Terbutaline is a fast-acting β2-adrenoceptor agonist (sympathomimetic) drug.
(GtoPdb)
DESCRIPTION
Terbutaline is an orally active ¦Â2-adrenergic receptor agonist and an active metabolite of bambuterol[1]. Terbutaline can be used in asthma symptom research[2].
PRICE
30
DESCRIPTION
Terbutaline is a short-acting agonist of ??2-adrenergic receptor (??2-AR) . It is an active metabolite of bambuterol
DESCRIPTION
Terbutaline sulfate is an orally active ¦Â2-adrenergic receptor agonist and an active metabolite of bambuterol[1]. Terbutaline sulfate can be used in asthma symptom research[2].
DESCRIPTION
beta-Adrenoceptor agonist; bronchodilator
(LOPAC library)
DESCRIPTION
Terbutaline is a selective beta-2 adrenergic receptor agonist. It is indicated for preventio and reversal of bronchospasm in patients at least 12 years old, with asthma and reversible bronchospasm associated with bronchitis and emphysema.
(Enamine Bioactive Compounds)
DESCRIPTION
Terbutaline Sulfate (Terbutaline hemisulfate) is a selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
33
BiasDB
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
Enamine BioReference Compounds
Guide to Pharmacology
Ki Database
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
Mcule NIBR MoA Box Subset
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Other bioactive compounds
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
71
Molecular Weight
225.14
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
4
Rotatable Bonds
3
Ring Count
1
Aromatic Ring Count
1
cLogP
1.52
TPSA
72.72
Fraction CSP3
0.5
Chiral centers
1.0
Largest ring
6.0
QED
0.63
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Selectivity
beta
Target
Adrenergic Receptor
antibiotic
Bacterial
β2-adrenergic receptor
¦Â2-adrenergic receptor
Drug Metabolite
Member status
member
MOA
beta2-Adrenoceptor Agonists
Pathway
GPCR/G protein
Microbiology/virology
Neuroscience
Anti-infection
Neuronal Signaling
Metabolic Enzyme/Protease
Therapeutic Class
Bronchodilator Agents
Source data
